136 related articles for article (PubMed ID: 33167891)
1. ZBTB7A functioned as an oncogene in colorectal cancer.
Wang L; Zhang MX; Zhang MF; Tu ZW
BMC Gastroenterol; 2020 Nov; 20(1):370. PubMed ID: 33167891
[TBL] [Abstract][Full Text] [Related]
2. Expression of Zinc Finger and BTB Domain-containing 7A in Colorectal Carcinoma.
Joo JW; Kim HS; Do SI; Sung JY
Anticancer Res; 2018 May; 38(5):2787-2792. PubMed ID: 29715100
[TBL] [Abstract][Full Text] [Related]
3. Somatic human ZBTB7A zinc finger mutations promote cancer progression.
Liu XS; Liu Z; Gerarduzzi C; Choi DE; Ganapathy S; Pandolfi PP; Yuan ZM
Oncogene; 2016 Jun; 35(23):3071-8. PubMed ID: 26455326
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of ZBTB7A exhibits a tumor suppressive role in gastric cancer cells.
Sun G; Peng B; Xie Q; Ruan J; Liang X
Mol Med Rep; 2018 Feb; 17(2):2635-2641. PubMed ID: 29207095
[TBL] [Abstract][Full Text] [Related]
5. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
[TBL] [Abstract][Full Text] [Related]
6. Role of ZBTB7A zinc finger in tumorigenesis and metastasis.
Singh AK; Verma S; Kushwaha PP; Prajapati KS; Shuaib M; Kumar S; Gupta S
Mol Biol Rep; 2021 May; 48(5):4703-4719. PubMed ID: 34014468
[TBL] [Abstract][Full Text] [Related]
7. MiR-106b regulates the apoptosis and tumorigenesis of hepatocellular carcinoma via targeting Zinc finger and BTB domain-containing protein 7A (Zbtb7a).
Liang X; Zhao Q; Geng T; Luo S; He Q
J Biochem Mol Toxicol; 2018 Aug; 32(8):e22169. PubMed ID: 29975452
[TBL] [Abstract][Full Text] [Related]
8. Low nuclear zinc finger and BTB domain containing 7A expression is an independent prognostic factor for recurrence-free survival in invasive ductal carcinoma of the breast.
Kim Y; Kim HS; Do SI
Int J Clin Exp Pathol; 2018; 11(4):2193-2200. PubMed ID: 31938331
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68.
Wang X; Yu H; Sun W; Kong J; Zhang L; Tang J; Wang J; Xu E; Lai M; Zhang H
Mol Cancer; 2018 Jul; 17(1):110. PubMed ID: 30064438
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of ZBTB7A as an oncogenic driver and transcriptional repressor.
Gupta S; Singh AK; Prajapati KS; Kushwaha PP; Shuaib M; Kumar S
Cancer Lett; 2020 Jul; 483():22-34. PubMed ID: 32348807
[TBL] [Abstract][Full Text] [Related]
11. ZBTB7A promotes migration, invasion and metastasis of human breast cancer cells through NF-κB-induced epithelial-mesenchymal transition in vitro and in vivo.
Mao A; Chen M; Qin Q; Liang Z; Jiang W; Yang W; Wei C
J Biochem; 2019 Dec; 166(6):485-493. PubMed ID: 31385585
[TBL] [Abstract][Full Text] [Related]
12. A Zbtb7a proto-oncogene as a novel target for miR-125a.
Hojo N; Tatsumi N; Moriguchi N; Matsumura A; Morimoto S; Nakata J; Fujiki F; Nishida S; Nakajima H; Tsuboi A; Oka Y; Hosen N; Hayashi S; Sugiyama H; Oji Y
Mol Carcinog; 2016 Dec; 55(12):2001-2009. PubMed ID: 26713860
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
[TBL] [Abstract][Full Text] [Related]
14. HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A.
Alam H; Li N; Dhar SS; Wu SJ; Lv J; Chen K; Flores ER; Baseler L; Lee MG
Cancer Res; 2018 Jul; 78(14):3834-3848. PubMed ID: 29764865
[TBL] [Abstract][Full Text] [Related]
15. ZBTB7A Mediates the Transcriptional Repression Activity of the Androgen Receptor in Prostate Cancer.
Han D; Chen S; Han W; Gao S; Owiredu JN; Li M; Balk SP; He HH; Cai C
Cancer Res; 2019 Oct; 79(20):5260-5271. PubMed ID: 31444154
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for transcription factor ZBTB7A recognition of DNA and effects of ZBTB7A somatic mutations that occur in human acute myeloid leukemia.
Ren R; Horton JR; Chen Q; Yang J; Liu B; Huang Y; Blumenthal RM; Zhang X; Cheng X
J Biol Chem; 2023 Feb; 299(2):102885. PubMed ID: 36626981
[TBL] [Abstract][Full Text] [Related]
17. LDB1 overexpression is a negative prognostic factor in colorectal cancer.
García SA; Swiersy A; Radhakrishnan P; Branchi V; Kanth Nanduri L; Győrffy B; Betzler AM; Bork U; Kahlert C; Reißfelder C; Rahbari NN; Weitz J; Schölch S
Oncotarget; 2016 Dec; 7(51):84258-84270. PubMed ID: 27713177
[TBL] [Abstract][Full Text] [Related]
18. Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis.
Liu Y; Wang G; Liang Z; Mei Z; Wu T; Cui A; Liu C; Cui L
Thorac Cancer; 2018 Jul; 9(7):785-793. PubMed ID: 29766649
[TBL] [Abstract][Full Text] [Related]
19. GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.
Nambara S; Masuda T; Kobayashi Y; Sato K; Tobo T; Koike K; Noda M; Ogawa Y; Kuroda Y; Ito S; Eguchi H; Sugimachi K; Mimori K
Cancer Sci; 2020 Feb; 111(2):343-355. PubMed ID: 31758608
[TBL] [Abstract][Full Text] [Related]
20. p62 functions as an oncogene in colorectal cancer through inhibiting apoptosis and promoting cell proliferation by interacting with the vitamin D receptor.
Zhang J; Yang S; Xu B; Wang T; Zheng Y; Liu F; Ren F; Jiang J; Shi H; Zou B; Lu X; Lu S; Dong L
Cell Prolif; 2019 May; 52(3):e12585. PubMed ID: 30793399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
